COPD Flashcards
CXR findings - COPD
hyperlucency (trapped air)
barrel chest
vertically oriented heart
flattened diaphragm
Normal decrease in FEV1 for non-smokers
25-30 mL/yr after age 35
Decrease in FEV1 for smokers
> 60 mL/yr
What scale can determine prognosis of COPD progression?
BODE
BMI
Obstruction (degree of airflow limitation)
Dyspnea
Exercise capacity (6 min walk test)
Goal of therapy for COPD
(NO CURE)
- symptom control
- prevention of exacerbations
What is the BEST intervention for COPD?
Stop smoking!
Anticholinergic Agents - MOA
acts on enzyme guanylate cyclase -> increases cGMP -> -> -> bronchodilation
What is the biggest issue with Ipatropium (SAMA)?
QID
MDI - need spacer or proper # of steps (harder to use)
Tiotropium - counseling for technique
pill form for inhalation…not for PO!
Tiotropium - class and indication
Long acting anti-cholinergic (LAMA)
COPD
Ipratropium - class and indication?
short acting anti-cholinergic (SAMA)
asthma exacerbation and COPD
ICS for COPD - who?
more severe patients (b/c higher risk of death and pneumonia)
GOLD 3 and 4 (FEV1<2L)
Roflumilast (Dalisresp) - class and indication
PDE4-inhib severe COPD (GOLD 3 and 4)
PDE-4 Enzyme Inhibitor (Roflumilast) - MOA
inhibits phosphodiesterase 4 (PDE4) which results in accumulation of cAMP in lungs –> anti-inflammatory, mild bronchodilation, remodeling
Roflumilast - ADE
weight loss - 20% lose 5-10%, 7% lose > 10%
this is a problem b/c already thin